• Circulating DNA Accurately Predicts for Prostate Cancer Prognosis

    Dec 17 | Diagnostics World | Sepsis ImmunoScore, the first FDA-authorized AI diagnostic for sepsis, has high accuracy for the diagnosis of sepsis and for prediction of key adverse patient outcomes, reports a paper published last week in the New England Journal of Medicine AI. In the paper, the authors write that the test showed both diagnostic and prognostic power. More

  • Sepsis AI Tool Validated for Both Diagnostic, Prognostic Use

    Dec 12 | Diagnostics World | Sepsis ImmunoScore, the first FDA-authorized AI diagnostic for sepsis, has high accuracy for the diagnosis of sepsis and for prediction of key adverse patient outcomes, reports a paper published last week in the New England Journal of Medicine AI. In the paper, the authors write that the test showed both diagnostic and prognostic power. More

  • Technology-Sharing Initiative Could Bring Multiplex PCR Testing Everywhere

    Dec 11 | Diagnostics World | A trio of publicly traded powerhouse companies—South Korea-based molecular diagnostics company Seegene, artificial intelligence (AI) and cloud service provider Microsoft, and global research publisher Springer Nature—are collaborating on an ambitious technology-sharing initiative that aims to better prepare the world for the next pandemic. More

  • Breathalyzer Developers Target Array of Diseases and Conditions

    Dec 10 | Diagnostics World | A number of research groups, companies, and collaboratives are pursuing breathalyzers aimed at tuberculosis, malaria, and other infectious diseases. Some of those same entities, and others, have also set their sights on applying breath-based technologies to a variety of other health concerns, including breast cancer, liver disease, gastrointestinal conditions, and lung disease. More

  • Researchers Accidentally Discover Genetic Signature for Early Detection of Sepsis in Newborns

    Dec 05 | Diagnostics World | Researchers from Simon Fraser University in Burnaby, Canada, and the University of British Columbia in Vancouver, Canada, have discovered a genetic signature in newborn infants that can predict neonatal sepsis before symptoms show. Neonatal sepsis is difficult to diagnose because of the nonspecific clinical signs that are often considered typical behavior issues in newborns, such as difficulty feeding and irritability. Therefore, most infants are not diagnosed until they start developing or have acquired the disease. More

  • Noninvasive Malaria Test Looks for Parasites in Circulating Blood

    Dec 03 | Diagnostics World | Most people in the United States have gotten no closer to malaria than the evening news, making the devasting nature of the infection in sub-Saharan Africa hard to fathom. Possibly once or more a day, people are being bitten by pathogen-carrying mosquitoes that cause untold hours of missed work and school and ultimately claim the lives of over half a million people—most of them young children. More

  • Follow the Money: Alimetry’s Wearable Gut Health Device, PrognomiQ Launches IVD, More

    Nov 26 | Diagnostics World | Alimetry plans to commercialize its wearable gut health monitoring device; PrognomiQ launches in vitro diagnostic; and more. More

  • NOWDiagnostics OTC Syphilis Test Now Available, Detecting Alzheimer’s Earliest Stages, More

    Nov 25 | Diagnostics World | NOWDiagnostics announced that its First To Know Syphilis Test, a key tool in syphilis prevention, is available for purchase nationwide; Veravas announced the results of an analytical verification study of its VeraBIND Tau assay, a next-generation test being co-developed with Phanes Biotech for the detection of Alzheimer’s disease at its earliest, most treatable stages; and more. More

  • Illumina Announces Update to TruSight Oncology Portfolio

    Nov 21 | Diagnostics World | Illumina announced an expansion of its TruSight Oncology portfolio this week at the annual meeting of the Association of Molecular Pathology (AMP) in Vancouver, British Columbia, with TruSight Oncology 500 v2 planned for global release in mid-2025. More

  • Urine Liquid Biopsy Promises Easy Cancer Detection with miRNA, ML

    Nov 19 | Diagnostics World | A team of researchers from Institute of Science Tokyo, Japan, are using nanowires with machine learning analysis to detect cancer-associated miRNAs in urine. Their research findings were published last month online in Analytical Chemistry. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more